| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 07/24/2007 | US7247629 Antitumoral analogs of et-743 |
| 07/24/2007 | US7247445 2-O sulfatase compositions and methods of hydrolyzing therewith |
| 07/19/2007 | WO2007081396A2 Initiators and crosslinkable polymeric materials |
| 07/19/2007 | WO2004100886A3 POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH THE NF-kB PATHWAY |
| 07/19/2007 | US20070169210 Modulators of gamete adhesion include polypeptides comprising at least one discoidin/C domain and optionally EGF domain; medical diagnosis; contraception; fertility |
| 07/19/2007 | US20070167425 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 07/19/2007 | US20070167409 Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and Conditions |
| 07/19/2007 | US20070166813 Gaucher disease drugs and methods of identifying same |
| 07/19/2007 | US20070166784 Combination approaches for generating immune responses |
| 07/19/2007 | US20070166710 Methods for inhibiting adipogenesis and for treating type 2 diabetes |
| 07/19/2007 | US20070166323 Yeast-dendritic cell vaccines and uses thereof |
| 07/19/2007 | US20070166284 Therapeutic regimen for treating cancer |
| 07/19/2007 | US20070166276 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro |
| 07/19/2007 | CA2624227A1 Initiators and crosslinkable polymeric materials |
| 07/18/2007 | EP1807404A1 Novel use |
| 07/18/2007 | EP1807042A1 Polyamine compositions |
| 07/18/2007 | EP1594854A4 Thiazolyl-based compounds useful as kinase inhibitors |
| 07/18/2007 | EP1373224B1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 07/18/2007 | EP1181021B1 Use of 4-thiouridine or isomaltitol for the treatment of inflammations and/or haemostasis |
| 07/18/2007 | EP1150678B1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 07/18/2007 | CN1326569C Pharmaceutical formulation of IRESSA comprising a water-soluble cellulose derivative |
| 07/18/2007 | CN101001631A Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| 07/18/2007 | CN100999501A Process for the preparation of 2-methyl piperazine derivatives |
| 07/17/2007 | US7244832 host cell tranformed with a nucleic acid encoding an antibody having a composite heavy chain with a variable domain including complementarity determining regions and framework regions comprising human acceptor antibody heavy chain framework region residues |
| 07/17/2007 | US7244751 N-(2-amino-5-fluorophenyl)-4-[N-(Pyridn-3-ylacryloyl)aminomethyl]benzamide or other derivatives for treating cancer and psoriasis |
| 07/17/2007 | US7244739 For treatment of neurodegenerative disorder, Alzheimer's disease; kits |
| 07/17/2007 | US7244732 Prodrugs of heteroaryl compounds |
| 07/17/2007 | US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy |
| 07/17/2007 | US7244615 Producing an antibody comprising complementarity determining regions, heavy and light chains, and non-human donor residues, a variable domain; used for in vivo therapy and diagnosis |
| 07/17/2007 | US7244580 Immunogenic composition for use in the diagnosis of allergies in mammals |
| 07/17/2007 | CA2348767C Method for producing an antitumoral agent and antitumoral agent thus obtained |
| 07/12/2007 | WO2005058249A3 Quinoa protein concentrate, production and functionality |
| 07/12/2007 | WO2005058229A3 Antiviral proteins with improved properties and methods therefor |
| 07/12/2007 | WO2005048925A3 Methods for treating a neoplastic disease in a subject using inorganic selenium-containing compounds |
| 07/12/2007 | WO2005037232A3 Methods and compositions for modulating adipocyte function |
| 07/12/2007 | WO2004112687A3 Antiviral acylguanidine compounds and methods |
| 07/12/2007 | WO2004066921A3 Erbb4 co-crystal |
| 07/12/2007 | US20070161666 Pyrrolo[2,3-d]pyrimidine compounds |
| 07/12/2007 | US20070161599 Composition for blocking hiv binding to dendritic cells and methods of use thereof |
| 07/12/2007 | US20070161582 Pharmaceutical compositions and methods for metabolic modulation |
| 07/12/2007 | US20070161556 Antifungal Therapeutic targets |
| 07/12/2007 | US20070161547 Modulation of survivin expression |
| 07/12/2007 | US20070161094 Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives |
| 07/12/2007 | US20070160692 Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| 07/12/2007 | US20070160685 Methods for treating a neoplastic disease in a subject using inorganic selenium-containing compounds |
| 07/12/2007 | US20070160659 Stabilized formulations of phosphatidylserine |
| 07/12/2007 | US20070160656 Lipid platinum complexes and methods of use thereof |
| 07/12/2007 | US20070160609 Interferon antagonists useful for the treatment of interferon related diseases |
| 07/12/2007 | US20070160605 Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody |
| 07/12/2007 | US20070160591 Peri-operative and peri-procedure nutritional supplementation |
| 07/12/2007 | US20070160580 Interferon gamma therapies for idiopathic pulmonary fibrosis |
| 07/11/2007 | EP1804828A2 The use of a protease or a protease inhibitor for the manufacture of medicaments |
| 07/11/2007 | EP1631597A4 Displaceable linker solid phase chemical ligation |
| 07/11/2007 | EP1284596B1 Apparatus and process for "in situ" manufacture of essence from living, uncut plants |
| 07/11/2007 | EP1175398B1 Indoline derivatives as progesterone antagonists |
| 07/11/2007 | CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/11/2007 | CN1325118C Ion composite type water-soluble pharmaceutical compositions, and use thereof |
| 07/11/2007 | CN1325035C Aqueous carrier systems for water-insoluble materials |
| 07/10/2007 | US7241899 Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B |
| 07/10/2007 | US7241877 Humanised antibodies |
| 07/10/2007 | US7241803 Compounds for inhibition of HIV infection by blocking HIV entry |
| 07/10/2007 | US7241782 Modifications are prepared by subjecting an alkaline solution of torasemide to a rapid acidification with inorganic or organic acids at 0 to 35 degrees C. |
| 07/10/2007 | US7241754 2-Desmethyl ansamycin compounds |
| 07/10/2007 | US7241448 T helper cell epitopes |
| 07/10/2007 | US7241300 Components, systems and methods for forming anastomoses using magnetism or other coupling means |
| 07/10/2007 | CA2396814C Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them |
| 07/10/2007 | CA2283564C Pharmaceutical compositions having appetite suppressant activity |
| 07/10/2007 | CA2162149C Antibodies to p-selectin and their uses |
| 07/05/2007 | WO2004069183A3 Immune regulation based on the targeting of early activation molecules |
| 07/05/2007 | US20070155950 Alkylated poly(allylamine) polymers and methods of use |
| 07/05/2007 | US20070155785 Hydroxamic acid compounds and methods of use thereof |
| 07/05/2007 | US20070155661 Methods and compositions for modulating the development of stem cells |
| 07/05/2007 | US20070154443 Cosmetic composition comprising camel milk or components thereof |
| 07/05/2007 | US20070154435 Compositions and methods for skin conditioning |
| 07/05/2007 | US20070152197 Thin lightweight flexible cloth, tor treatment of garments with high molecular weight metal particles; for the manufacture of radiation attenuation garments; X-ray shielding garments |
| 07/04/2007 | EP1569636A4 Use of equol for treating androgen mediated diseases |
| 07/04/2007 | CN1990474A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 07/04/2007 | CN1990469A Pyrrolidines as dipeptidyl peptidase inhibitors |
| 07/04/2007 | CN1990468A Pyrrolidines as dipeptidyl peptidase inhibitors |
| 07/04/2007 | CN1323664C Sustained release ranolazine formulations |
| 07/03/2007 | US7238723 Indole derivatives |
| 07/03/2007 | US7238704 For use as inhibitors of cellular mitosis and proliferation |
| 07/03/2007 | US7238683 (Cycloalkyleneiminocarbonyl)-indanyl- or -tetrahydronaphthyl- methylamines, e.g., {(1S)-1-[(1S)-5-(4-Fluorophenyl)-2,3-dihydro-1H-inden-1-yl]-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethyl}amine hydrochloride; particularly for treating type 2 diabetes |
| 07/03/2007 | US7238343 Cosmetic method and composition for enhancing attractiveness |
| 07/03/2007 | CA2447510C Fluorocarbon aerosol medicaments |
| 07/03/2007 | CA2433177C Hypoallergenic and non-irritant skin care formulations |
| 06/28/2007 | WO2005055944A3 Oligosaccharide compositions and use thereof in the treatment of infection |
| 06/28/2007 | WO2005033278A8 In vivo efficacy of ny-eso-1 plus iscom |
| 06/28/2007 | WO2004075850A3 Polyvalent immunogen |
| 06/28/2007 | US20070149591 Compositions of a cyclooxygenase-2 selective inhibitor administered under hypothermic conditions for the treatment of ischemic mediated central nervous system disorders or injury |
| 06/28/2007 | US20070149500 Compounds, compositions, and methods |
| 06/28/2007 | US20070149468 Methods and compositions for rna interference |
| 06/28/2007 | US20070149448 chronic ulcers; cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media |
| 06/28/2007 | US20070149446 Tamandarin analogs and fragments thereof and methods of making and using |
| 06/28/2007 | US20070148258 Dialysates and methods and systems related thereto |
| 06/28/2007 | US20070148255 Compositions for delivery of drug combinations |
| 06/28/2007 | US20070148192 Stable ophthalmic composition |
| 06/28/2007 | US20070148188 Anthrax vaccine |
| 06/28/2007 | US20070148181 Ganglioside based vaccine compositions for subcutaneous administration |
| 06/28/2007 | US20070148160 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |